Last reviewed · How we verify
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
A 6-week double-blind study to evaluate the safety and efficacy of Quillichew extended release chewable tablets in 4-5 year old children with attention deficit hyperactivity disorder.
Details
| Lead sponsor | Pfizer |
|---|---|
| Phase | PHASE4 |
| Status | WITHDRAWN |
| Start date | Wed Oct 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- Attention Deficit Hyperactivity Disorder
Interventions
- methylphenidate HCl ERCT
- Placebo